| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 63 |
| 1 | CIPROFLOXACIN HYDROCHLORIDE | 44 |
| 2 | RITONAVIR | 42 |
| 3 | CIPROFLOXACIN | 41 |
| 4 | CIPROFLOXACIN TABLETS | 35 |
| 5 | CIPROFOLXACIN | 35 |
| 6 | LAMIVUDINE AND ZIDOVUDINE | 35 |
| 7 | LAMIVUDINE ORAL | 35 |
| 8 | LOPINAVIR AND RITONAVIR | 31 |
| 9 | ZIDOVUDINE | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL, UNSPECIFIED | 1 | 0.0100 |
| 1 | ESTRONE | 1 | 0.0093 |
| 2 | LAMIVUDINE AND ZIDOVUDINE | 35 | 0.0045 |
| 3 | NELFINAVIR MESYLATE | 9 | 0.0043 |
| 4 | TRIMIPRAMINE | 4 | 0.0036 |
| 5 | MANGANESE CHLORIDE | 1 | 0.0036 |
| 6 | FOSFOMYCIN TROMETHAMINE | 2 | 0.0033 |
| 7 | ZIDOVUDINE | 31 | 0.0030 |
| 8 | ABACAVIR SULFATE | 25 | 0.0026 |
| 9 | LAMIVUDINE | 63 | 0.0025 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 96 | 0.0020 |
| 1 | Leptin Analog [EPC] | 2 | 0.0016 |
| 2 | Carnitine Analog [EPC] | 5 | 0.0014 |
| 3 | Protease Inhibitor [EPC] | 60 | 0.0013 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 113 | 0.0010 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 60 | 0.0010 |
| 6 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 19 | 0.0008 |
| 8 | Paramagnetic Contrast Agent [EPC] | 3 | 0.0007 |
| 9 | Gadolinium-based Contrast Agent [EPC] | 3 | 0.0006 |